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Abstract 
INTRODUCTION:  
Psoriasis is a chronic skin disorder associated with several comorbid conditions. In psoriasis 
pathogenesis, the role of some cytokines, including TNF-α and IL-17, has been elucidated. Beside 
their pro-inflammatory activity, they may also affect glucose and lipid metabolism, possibly 
promoting insulin resistance and obesity. On the other hand, adipose tissue, secreting adipokines 
such as chemerin, visfatin, leptin, and adiponectin, not only regulates glucose and lipid metabolism, 
and endothelial cell function regulation, but it may contribute to inflammation. 
AREAS COVERED:  
This review provides an updated 'state-of-the-art' about the reciprocal contribution of a small subset 
of conventional cytokines and adipokines involved in chronic inflammatory pathways, upregulated 
in both psoriasis and increased adiposity. A systematic search was conducted using the PubMed 
Medline database for primary articles. Expert commentary: Because psoriasis is associated with 
increased adiposity, it would be important to define the contribution of chronic skin inflammation to 
the onset of obesity and vice versa. Clarifying the pathogenic mechanism underlying this 
association, a therapeutic strategy having favorable effects on both psoriasis and increased adiposity 
could be identified. 
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